HCA Healthcare is trading at $436.00, down 5.90%, after its third-quarter report highlighted a roughly $400 million quarterly payer-mix impact from rising uninsured volume.

  • Its October 27 third-quarter results beat estimates.
  • Management expects 2026 results in the upper half of its prior guidance range; coverage losses and a more cautious 2027 earnings outlook may be weighing on sentiment.
  • Search results surfaced no separate October 28 company announcement explaining the after-hours move.